(CAMP) is a Biotechnology Research company. CAMP4 is a company that provides a rap platform, rna actuators, programmable therapeutics, publications and presentations, pipeline, and investors. They also have a newsroom and a newsroom for investors. CAMP4 Therapeutics employs 50 people (-4.8% YoY, -3 people) and has an annual revenue of $3.2M, founded in 2016. Headquartered in Cambridge, Massachusetts, United States. IPO 2024. ... At CAMP4 Therapeutics, we are pioneering a novel approach to p